Search 

Alcyomics a proven, experienced CRO and service-provider, Alcyomics has developed unique non-animal non-artificial human based in vitro assays that transform drug development by enabling early and accurate identification of safe and efficacious compounds. Our sensitive and highly customisable assays significantly improve the testing process making it faster, more effective and better at predicting clinical outcomes. We help clients reduce the cost of drug development, reduce the use of animal models and improve speed to market whilst providing a better return on investment. Our platform is fully human, sensitive and a cost effective approach for both toxicity and efficacy studies.

The Cell and Gene Therapy Catapult is an independent innovation and technology organisation committed to the advancement of the CGT industry with a vision of a thriving industry delivering life changing advanced therapies to the world. Its aim is to create powerful collaborations which overcome challenges to the advancement of the sector. With over 400 experts covering all aspects of advanced therapies, it applies its unique capabilities and assets, collaborates with academia, industry and healthcare providers to develop new technology and innovation.